Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Oct;33(5):901-907.
doi: 10.1007/s40620-020-00797-y. Epub 2020 Jul 12.

Renal structure in type 2 diabetes: facts and misconceptions

Affiliations
Review

Renal structure in type 2 diabetes: facts and misconceptions

Angelo Di Vincenzo et al. J Nephrol. 2020 Oct.

Abstract

The clinical manifestations of diabetic nephropathy are similar in type 1 and type 2 diabetes, while the renal lesions may differ. Indeed, diabetic glomerulopathy is the predominant renal lesion in type 1 diabetes, although also tubular, interstitial and arteriolar lesions are present in the advanced stages of renal disease. In contrast, in type 2 diabetes renal lesions are heterogeneous, and a substantial number of type 2 diabetic patients with diabetic kidney disease have mild or absent glomerulopathy with tubulointerstitial and/or arteriolar abnormalities. In addition, a high prevalence of non-diabetic renal diseases, isolated or superimposed on classic diabetic nephropathy lesions have been reported in patients with type 2 diabetes, often reflecting the bias of selecting patients for unusual clinical presentations for renal biopsy. This review focuses on renal structural changes in type 2 diabetes, emphasizing the contribution of research kidney biopsy studies to the understanding of the pathogenesis of DKD and of the structural lesions responsible for the different clinical phenotypes. Also, kidney biopsies could provide relevant information in terms of renal prognosis, and help to understand the different responses to different therapies, especially SGLT2 inhibitors, thus allowing personalized medicine.

Keywords: Diabetic nephropathy; Kidney biopsy; Mesangial expansion; Morphometric analysis; Tubulointerstitial lesions.

PubMed Disclaimer

Conflict of interest statement

On behalf of all authors, the corresponding author states that there is no conflict of interest.

References

    1. https://www.usrds.org/2019/view/USRDS_2019_ES_final.pdf
    1. https://www.era-edta-reg.org/files/annualreports/pdf/AnnRep2016.pdf.
    1. Giorda CB, Carna P, Salomone M, et al. Ten-year comparative analysis of incidence, prognosis, and associated factors for dialysis and renal transplantation in type 1 and type 2 diabetes versus non-diabetes. Acta Diabetol. 2018;55:733–740. - PubMed
    1. Chronic Kidney Disease Prognosis Consortium. Matsushita K, van der Velde M, et al. Association of estimatef glomerular filtration rate and albuminuria and all-cause and cardiovascular mortality in genetral population cohorts: a collaborative meta-analysis. Lancet. 2010;375:2073–20181. - PMC - PubMed
    1. Mazzucco G, Bertani T, Fortunato M, et al. Different patterns of renal damage in type 2 diabetes mellitus: a multicentric study on 393 biopsies. AJKD. 2002;39:713–720. - PubMed